MoneyWorks4Me

Glenmark Life Scienc - Quaterly Results

04 Aug 2022 Evaluate
The sales slipped to Rs. 4898.70 millions for the June 2022 quarter as against Rs. 5248.97 millions during the year-ago period.A humble growth in net profit of 7.75% reported in the quarter ended June 2022 to Rs. 1087.33  millions from Rs. 1009.13 millions.The Operating Profit of the company witnessed a decrease to 1562.61 millions from 1644.34 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 4898.70 5248.97 -6.67 4898.70 5248.97 -6.67 21232.14 18851.65 12.63
Other Income 94.93 39.86 138.16 94.93 39.86 138.16 147.04 8.11 1713.07
PBIDT 1562.61 1644.34 -4.97 1562.61 1644.34 -4.97 6307.64 5918.85 6.57
Interest 1.35 205.50 -99.34 1.35 205.50 -99.34 279.62 875.47 -68.06
PBDT 1561.26 1438.84 8.51 1561.26 1438.84 8.51 6028.02 5043.38 19.52
Depreciation 98.79 89.19 10.76 98.79 89.19 10.76 378.77 333.94 13.42
PBT 1462.47 1349.65 8.36 1462.47 1349.65 8.36 5649.25 4709.44 19.96
TAX 375.14 340.52 10.17 375.14 340.52 10.17 1462.01 1193.63 22.48
Deferred Tax 12.85 18.09 -28.97 12.85 18.09 -28.97 85.74 66.17 29.58
PAT 1087.33 1009.13 7.75 1087.33 1009.13 7.75 4187.24 3515.81 19.10
Equity 245.05 215.61 13.65 245.05 215.61 13.65 245.05 19.60 1150.26
PBIDTM(%) 31.90 31.33 1.82 31.90 31.33 1.82 29.71 31.40 -5.38
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1225.15
Cipla 1389.90
Lupin 2066.00
Zydus Lifesciences 1217.70
View more..